AAAAAA

   
Results: 1-13 |
Results: 13
Creatine increases survival and delays motor symptoms in a transgenic animal model of Huntington's disease
Authors: Andreassen, OA Dedeoglu, A Ferrante, RJ Jenkins, BG Ferrante, KL Thomas, M Friedlich, A Browne, SE Schilling, G Borchelt, DR Hersch, SM Ross, CA Beal, MF
Citation: Oa. Andreassen et al., Creatine increases survival and delays motor symptoms in a transgenic animal model of Huntington's disease, NEUROBIOL D, 8(3), 2001, pp. 479-491
A novel procedure for pre-embedding double immunogold-silver labeling at the ultrastructural level
Authors: Yi, H Leunissen, JLM Shi, GM Gutekunst, CA Hersch, SM
Citation: H. Yi et al., A novel procedure for pre-embedding double immunogold-silver labeling at the ultrastructural level, J HIST CYTO, 49(3), 2001, pp. 279-283
Muscarinic m1 and m2 receptor proteins in local circuit and projection neurons of the primate striatum: Anatomical evidence for cholinergic modulation of glutamatergic prefronto-striatal pathways
Authors: Alcantara, AA Mrzljak, L Jakab, RL Levey, AI Hersch, SM Goldman-Rakic, PS
Citation: Aa. Alcantara et al., Muscarinic m1 and m2 receptor proteins in local circuit and projection neurons of the primate striatum: Anatomical evidence for cholinergic modulation of glutamatergic prefronto-striatal pathways, J COMP NEUR, 434(4), 2001, pp. 445-460
Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease
Authors: Chen, M Ona, VO Li, MW Ferrante, RJ Fink, KB Zhu, S Bian, J Guo, L Farrell, LA Hersch, SM Hobbs, W Vonsattel, JP Cha, JHJ Friedlander, RM
Citation: M. Chen et al., Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease, NAT MED, 6(7), 2000, pp. 797
Cortical inputs to m2-immunoreactive striatal interneurons in rat and monkey
Authors: Thomas, TM Smith, Y Levey, AI Hersch, SM
Citation: Tm. Thomas et al., Cortical inputs to m2-immunoreactive striatal interneurons in rat and monkey, SYNAPSE, 37(4), 2000, pp. 252-261
Neuroprotective effects of creatine in a transgenic mouse model of Huntington's disease
Authors: Ferrante, RJ Andreassen, OA Jenkins, BG Dedeoglu, A Kuemmerle, S Kubilus, JK Kaddurah-Daouk, R Hersch, SM Beal, MF
Citation: Rj. Ferrante et al., Neuroprotective effects of creatine in a transgenic mouse model of Huntington's disease, J NEUROSC, 20(12), 2000, pp. 4389-4397
Transplanted fetal striatum in Huntington's disease: Phenotypic development and lack of pathology
Authors: Freeman, TB Cicchetti, F Hauser, RA Deacon, TW Li, XJ Hersch, SM Nauert, GM Sanberg, PR Kordower, JH Saporta, S Isacson, O
Citation: Tb. Freeman et al., Transplanted fetal striatum in Huntington's disease: Phenotypic development and lack of pathology, P NAS US, 97(25), 2000, pp. 13877-13882
Evidence for both the nucleus and cytoplasm as subcellular sites of pathogenesis in Huntington's disease in cell culture and in transgenic mice expressing mutant huntingtin
Authors: Hackam, AS Hodgson, JG Singaraja, R Zhang, TQ Gan, L Gutekunst, CA Hersch, SM Hayden, MR
Citation: As. Hackam et al., Evidence for both the nucleus and cytoplasm as subcellular sites of pathogenesis in Huntington's disease in cell culture and in transgenic mice expressing mutant huntingtin, PHI T ROY B, 354(1386), 1999, pp. 1047-1055
A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration
Authors: Hodgson, JG Agopyan, N Gutekunst, CA Leavitt, BR LePiane, F Singaraja, R Smith, DJ Bissada, N McCutcheon, K Nasir, J Jamot, L Li, XJ Stevens, ME Rosemond, E Roder, JC Phillips, AG Rubin, EM Hersch, SM Hayden, MR
Citation: Jg. Hodgson et al., A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration, NEURON, 23(1), 1999, pp. 181-192
Huntingtin aggregates may not predict neuronal death in Huntington's disease
Authors: Kuemmerle, S Gutekunst, CA Klein, AM Li, XJ Li, SH Beal, MF Hersch, SM Ferrante, RJ
Citation: S. Kuemmerle et al., Huntingtin aggregates may not predict neuronal death in Huntington's disease, ANN NEUROL, 46(6), 1999, pp. 842-849
Nuclear and neuropil aggregates in Huntington's disease: Relationship to neuropathology
Authors: Gutekunst, CA Li, SH Yi, H Mulroy, JS Kuemmerle, S Jones, R Rye, D Ferrante, RJ Hersch, SM Li, XJ
Citation: Ca. Gutekunst et al., Nuclear and neuropil aggregates in Huntington's disease: Relationship to neuropathology, J NEUROSC, 19(7), 1999, pp. 2522-2534
Tissue heterogeneity of the FMR1 mutation in a high-functioning male with fragile X syndrome
Authors: Taylor, AK Tassone, F Dyer, PN Hersch, SM Harris, JB Greenough, WT Hagerman, RJ
Citation: Ak. Taylor et al., Tissue heterogeneity of the FMR1 mutation in a high-functioning male with fragile X syndrome, AM J MED G, 84(3), 1999, pp. 233-239
A human HAP1 homologue. Cloning, expression, and interaction with Huntingtin (vol 273, pg 19220, 1998)
Authors: Li, SH Hosseini, SH Gutekunst, CA Hersch, SM Ferrante, RJ Li, XJ
Citation: Sh. Li et al., A human HAP1 homologue. Cloning, expression, and interaction with Huntingtin (vol 273, pg 19220, 1998), J BIOL CHEM, 274(14), 1999, pp. 9906-9906
Risultati: 1-13 |